{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:06:21Z","timestamp":1790877981730,"version":"4.1.0"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T00:00:00Z","timestamp":1616025600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The number of people affected by Type 2 diabetes mellitus (T2DM) is close to half a billion and is on a sharp rise, representing a major and growing public health burden. Given its mild initial symptoms, T2DM is often diagnosed several years after its onset, leaving half of diabetic individuals undiagnosed. While several classical clinical and genetic biomarkers have been identified, improving early diagnosis by exploring other kinds of omics data remains crucial. In this study, we have combined longitudinal data from two population-based cohorts CoLaus and DESIR (comprising in total 493 incident cases vs. 1360 controls) to identify new or confirm previously implicated metabolomic biomarkers predicting T2DM incidence more than 5\u00a0years ahead of clinical diagnosis. Our longitudinal data have shown robust evidence for valine, leucine, carnitine and glutamic acid being predictive of future conversion to T2DM. We confirmed the causality of such association for leucine by 2-sample Mendelian randomisation (MR) based on independent data. Our MR approach further identified new metabolites potentially playing a causal role on T2D, including betaine, lysine and mannose. Interestingly, for valine and leucine a strong reverse causal effect was detected, indicating that the genetic predisposition to T2DM may trigger early changes of these metabolites, which appear well-before any clinical symptoms. In addition, our study revealed a reverse causal effect of metabolites such as glutamic acid and alanine. Collectively, these findings indicate that molecular traits linked to the genetic basis of T2DM may be particularly promising early biomarkers.<\/jats:p>","DOI":"10.1038\/s41598-021-85684-7","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T12:48:15Z","timestamp":1616071695000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Triangulating evidence from longitudinal and Mendelian randomization studies of metabolomic biomarkers for type 2 diabetes"],"prefix":"10.1038","volume":"11","author":[{"given":"Eleonora","family":"Porcu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Gilardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liza","family":"Darrous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Yengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nasim","family":"Bararpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Gasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Marques-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Waeber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelien","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Kutalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,18]]},"reference":[{"issue":"7","key":"85684_CR1","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.3390\/jcm9072207","volume":"9","author":"LA Tucker","year":"2020","unstructured":"Tucker, L. A. Limited agreement between classifications of diabetes and prediabetes resulting from the OGTT, hemoglobin A1c, and fasting glucose tests in 7412 Us Adults. J. Clin. Med. 9(7), 2207 (2020).","journal-title":"J. Clin. Med."},{"issue":"1","key":"85684_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1007\/s12010-019-03080-4","volume":"190","author":"MA Serdar","year":"2020","unstructured":"Serdar, M. A. et al. An assessment of HbA1c in diabetes mellitus and pre-diabetes diagnosis: a multi-centered data mining study. Appl. Biochem. Biotechnol. 190(1), 44\u201356 (2020).","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"5","key":"85684_CR3","doi-asserted-by":"publisher","first-page":"832","DOI":"10.2337\/dc18-2342","volume":"42","author":"M Kyi","year":"2019","unstructured":"Kyi, M. et al. Early intervention for diabetes in medical and surgical inpatients decreases hyperglycemia and hospital-acquired infections: a cluster randomized trial. Diabetes Care 42(5), 832\u2013840 (2019).","journal-title":"Diabetes Care"},{"issue":"11","key":"85684_CR4","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00125-020-05253-x","volume":"63","author":"S Yuan","year":"2020","unstructured":"Yuan, S. & Larsson, S. C. An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study. Diabetologia 63(11), 2359\u20132371 (2020).","journal-title":"Diabetologia"},{"issue":"10","key":"85684_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.molmet.2016.08.011","volume":"5","author":"L Yengo","year":"2016","unstructured":"Yengo, L. et al. Impact of statistical models on the prediction of type 2 diabetes using non-targeted metabolomics profiling. Mol. Metab. 5(10), 918\u2013925 (2016).","journal-title":"Mol. Metab."},{"issue":"5","key":"85684_CR6","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1056\/NEJMoa1803760","volume":"379","author":"W Fenske","year":"2018","unstructured":"Fenske, W. et al. A copeptin-based approach in the diagnosis of diabetes insipidus. N. Engl. J. Med. 379(5), 428\u2013439 (2018).","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"85684_CR7","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1210\/er.2019-00088","volume":"40","author":"MS Udler","year":"2019","unstructured":"Udler, M. S. et al. Genetic risk scores for diabetes diagnosis and precision medicine. Endocr. Rev. 40(6), 1500\u20131520 (2019).","journal-title":"Endocr. Rev."},{"issue":"12","key":"85684_CR8","doi-asserted-by":"publisher","first-page":"4270","DOI":"10.2337\/db13-0570","volume":"62","author":"C Menni","year":"2013","unstructured":"Menni, C. et al. Biomarkers for Type 2 diabetes and impaired fasting glucose using a nontargeted metabolomics approach. Diabetes 62(12), 4270\u20134276 (2013).","journal-title":"Diabetes"},{"key":"85684_CR9","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1038\/msb.2012.43","volume":"8","author":"R Wang-Sattler","year":"2012","unstructured":"Wang-Sattler, R. et al. Novel biomarkers for pre-diabetes identified by metabolomics. Mol. Syst. Biol. 8, 615 (2012).","journal-title":"Mol. Syst. Biol."},{"issue":"2","key":"85684_CR10","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel, A. et al. Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2), 639\u2013648 (2013).","journal-title":"Diabetes"},{"issue":"1","key":"85684_CR11","doi-asserted-by":"publisher","first-page":"e85082","DOI":"10.1371\/journal.pone.0085082","volume":"9","author":"I Padberg","year":"2014","unstructured":"Padberg, I. et al. A new metabolomic signature in type-2 diabetes mellitus and its pathophysiology. PLoS ONE 9(1), e85082 (2014).","journal-title":"PLoS ONE"},{"issue":"4","key":"85684_CR12","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17(4), 448\u2013453 (2011).","journal-title":"Nat. Med."},{"issue":"5","key":"85684_CR13","doi-asserted-by":"publisher","first-page":"833","DOI":"10.2337\/dc15-2251","volume":"39","author":"M Guasch-Ferre","year":"2016","unstructured":"Guasch-Ferre, M. et al. Metabolomics in prediabetes and diabetes: a systematic review and meta-analysis. Diabetes Care 39(5), 833\u2013846 (2016).","journal-title":"Diabetes Care"},{"issue":"3","key":"85684_CR14","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1210\/jc.2017-02139","volume":"103","author":"E Strand","year":"2018","unstructured":"Strand, E. et al. Serum carnitine metabolites and incident type 2 diabetes mellitus in patients with suspected stable angina pectoris. J. Clin. Endocrinol. Metab. 103(3), 1033\u20131041 (2018).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"9","key":"85684_CR15","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1016\/j.celrep.2017.02.019","volume":"18","author":"L Wigger","year":"2017","unstructured":"Wigger, L. et al. Plasma dihydroceramides are diabetes susceptibility biomarker candidates in mice and humans. Cell Rep. 18(9), 2269\u20132279 (2017).","journal-title":"Cell Rep."},{"issue":"9","key":"85684_CR16","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1007\/s11306-017-1239-2","volume":"13","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. Metabolomics based markers predict type 2 diabetes in a 14-year follow-up study. Metabolomics 13(9), 104 (2017).","journal-title":"Metabolomics"},{"issue":"2","key":"85684_CR17","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1001\/archinte.172.2.188","volume":"172","author":"R Schmid","year":"2012","unstructured":"Schmid, R. et al. Validation of 7 type 2 diabetes mellitus risk scores in a population-based cohort: CoLaus study. Arch. Intern. Med. 172(2), 188\u2013189 (2012).","journal-title":"Arch. Intern. Med."},{"issue":"4","key":"85684_CR18","first-page":"373","volume":"44","author":"B Balkau","year":"1996","unstructured":"Balkau, B. An epidemiologic survey from a network of French health examination centres. (DESIR: Epidemiologic data on the insulin resistance syndrome). Rev. D Epidemiol. Et De Sante Publ. 44(4), 373\u2013375 (1996).","journal-title":"Rev. D Epidemiol. Et De Sante Publ."},{"issue":"11","key":"85684_CR19","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1007\/s00125-013-3021-y","volume":"56","author":"F Bonnet","year":"2013","unstructured":"Bonnet, F. et al. Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts. Diabetologia 56(11), 2414\u20132423 (2013).","journal-title":"Diabetologia"},{"issue":"8","key":"85684_CR20","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00125-014-3277-x","volume":"57","author":"M Vaxillaire","year":"2014","unstructured":"Vaxillaire, M. et al. Type 2 diabetes-related genetic risk scores associated with variations in fasting plasma glucose and development of impaired glucose homeostasis in the prospective DESIR study. Diabetologia 57(8), 1601\u20131610 (2014).","journal-title":"Diabetologia"},{"issue":"5","key":"85684_CR21","first-page":"428","volume":"23","author":"B Balkau","year":"1997","unstructured":"Balkau, B. et al. Proposed criteria for the diagnosis of diabetes: evidence from a French epidemiological study (DESIR). Diabetes Metab. 23(5), 428\u2013434 (1997).","journal-title":"Diabetes Metab."},{"issue":"9","key":"85684_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/s41592-018-0110-3","volume":"15","author":"X Domingo-Almenara","year":"2018","unstructured":"Domingo-Almenara, X. et al. XCMS-MRM and METLIN-MRM: a cloud library and public resource for targeted analysis of small molecules. Nat. Methods 15(9), 681\u2013684 (2018).","journal-title":"Nat. Methods"},{"key":"85684_CR23","doi-asserted-by":"crossref","unstructured":"Bararpour, N., et al. Visualization and normalization of drift effect across batches in metabolome-wide association studies. bioRxiv (2020).","DOI":"10.1101\/2020.01.22.914051"},{"issue":"1","key":"85684_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ije\/dyg070","volume":"32","author":"GD Smith","year":"2003","unstructured":"Smith, G. D. & Ebrahim, S. \u201cMendelian randomization\u201d: Can genetic epidemiology contribute to understanding environmental determinants of disease?. Int. J. Epidemiol. 32(1), 1\u201322 (2003).","journal-title":"Int. J. Epidemiol."},{"issue":"6","key":"85684_CR25","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/ng.2982","volume":"46","author":"SY Shin","year":"2014","unstructured":"Shin, S. Y. et al. An atlas of genetic influences on human blood metabolites. Nat. Genet. 46(6), 543\u2013550 (2014).","journal-title":"Nat. Genet."},{"issue":"11","key":"85684_CR26","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.2337\/db16-1253","volume":"66","author":"RA Scott","year":"2017","unstructured":"Scott, R. A. et al. An expanded genome-wide association study of type 2 diabetes in Europeans. Diabetes 66(11), 2888\u20132902 (2017).","journal-title":"Diabetes"},{"issue":"4","key":"85684_CR27","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1111\/jdi.12345","volume":"6","author":"X Chen","year":"2015","unstructured":"Chen, X. & Yang, W. Branched-chain amino acids and the association with type 2 diabetes. J. Diabetes Investig. 6(4), 369\u2013370 (2015).","journal-title":"J. Diabetes Investig."},{"issue":"5","key":"85684_CR28","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db12-0707","volume":"62","author":"E Ferrannini","year":"2013","unstructured":"Ferrannini, E. et al. Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance. Diabetes 62(5), 1730\u20131737 (2013).","journal-title":"Diabetes"},{"issue":"3","key":"85684_CR29","doi-asserted-by":"publisher","first-page":"E463","DOI":"10.1210\/jc.2014-2357","volume":"100","author":"ND Palmer","year":"2015","unstructured":"Palmer, N. D. et al. Metabolomic profile associated with insulin resistance and conversion to diabetes in the insulin resistance atherosclerosis study. J. Clin. Endocrinol. Metab. 100(3), E463\u2013E468 (2015).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"85684_CR30","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.2337\/dc11-1838","volume":"35","author":"P Wurtz","year":"2012","unstructured":"Wurtz, P. et al. Circulating metabolite predictors of glycemia in middle-aged men and women. Diabetes Care 35(8), 1749\u20131756 (2012).","journal-title":"Diabetes Care"},{"issue":"12","key":"85684_CR31","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","volume":"62","author":"AV Ahola-Olli","year":"2019","unstructured":"Ahola-Olli, A. V. et al. Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts. Diabetologia 62(12), 2298\u20132309 (2019).","journal-title":"Diabetologia"},{"issue":"4","key":"85684_CR32","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1007\/s00125-017-4521-y","volume":"61","author":"L Shi","year":"2018","unstructured":"Shi, L. et al. Plasma metabolites associated with type 2 diabetes in a Swedish population: a case-control study nested in a prospective cohort. Diabetologia 61(4), 849\u2013861 (2018).","journal-title":"Diabetologia"},{"issue":"3","key":"85684_CR33","doi-asserted-by":"publisher","first-page":"38","DOI":"10.4239\/wjd.v3.i3.38","volume":"3","author":"BC Melnik","year":"2012","unstructured":"Melnik, B. C. Leucine signaling in the pathogenesis of type 2 diabetes and obesity. World J. Diabetes 3(3), 38\u201353 (2012).","journal-title":"World J. Diabetes"},{"issue":"3","key":"85684_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.2337\/diabetes.51.3.599","volume":"51","author":"M Krebs","year":"2002","unstructured":"Krebs, M. et al. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51(3), 599\u2013605 (2002).","journal-title":"Diabetes"},{"issue":"7","key":"85684_CR35","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.2337\/db11-1378","volume":"61","author":"A Stancakova","year":"2012","unstructured":"Stancakova, A. et al. Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men. Diabetes 61(7), 1895\u20131902 (2012).","journal-title":"Diabetes"},{"issue":"18","key":"85684_CR36","doi-asserted-by":"publisher","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","volume":"125","author":"S Cheng","year":"2012","unstructured":"Cheng, S. et al. Metabolite profiling identifies pathways associated with metabolic risk in humans. Circulation 125(18), 2222\u20132231 (2012).","journal-title":"Circulation"},{"issue":"4","key":"85684_CR37","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1210\/clinem\/dgz240","volume":"105","author":"Y Sun","year":"2020","unstructured":"Sun, Y. et al. Metabolomics signatures in type 2 diabetes: a systematic review and integrative analysis. J. Clin. Endocrinol. Metab. 105(4), 1000\u20131008 (2020).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"85684_CR38","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cmet.2009.05.001","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9(6), 565\u2013566 (2009).","journal-title":"Cell Metab."},{"issue":"6","key":"85684_CR39","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.cmet.2008.03.004","volume":"7","author":"O Cabrera","year":"2008","unstructured":"Cabrera, O. et al. Glutamate is a positive autocrine signal for glucagon release. Cell Metab. 7(6), 545\u2013554 (2008).","journal-title":"Cell Metab."},{"issue":"7","key":"85684_CR40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s11306-018-1383-3","volume":"14","author":"SY Rhee","year":"2018","unstructured":"Rhee, S. Y. et al. Plasma glutamine and glutamic acid are potential biomarkers for predicting diabetic retinopathy. Metabolomics 14(7), 89 (2018).","journal-title":"Metabolomics"},{"issue":"7","key":"85684_CR41","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/sj.ejcn.1602594","volume":"61","author":"A Poorabbas","year":"2007","unstructured":"Poorabbas, A. et al. Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur. J. Clin. Nutr. 61(7), 892\u2013895 (2007).","journal-title":"Eur. J. Clin. Nutr."},{"issue":"1","key":"85684_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-011-0284-2","volume":"51","author":"R Ringseis","year":"2012","unstructured":"Ringseis, R., Keller, J. & Eder, K. Role of carnitine in the regulation of glucose homeostasis and insulin sensitivity: evidence from in vivo and in vitro studies with carnitine supplementation and carnitine deficiency. Eur. J. Nutr. 51(1), 1\u201318 (2012).","journal-title":"Eur. J. Nutr."},{"issue":"1","key":"85684_CR43","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1111\/nyas.13217","volume":"1391","author":"JJ Joseph","year":"2017","unstructured":"Joseph, J. J. & Golden, S. H. Cortisol dysregulation: the bidirectional link between stress, depression, and type 2 diabetes mellitus. Ann. N. Y. Acad. Sci. 1391(1), 20\u201334 (2017).","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"3","key":"85684_CR44","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1093\/ajcn\/nqy262","volume":"109","author":"C Papandreou","year":"2019","unstructured":"Papandreou, C. et al. Plasma metabolites predict both insulin resistance and incident type 2 diabetes: a metabolomics approach within the prevencion con dieta mediterranea (PREDIMED) study. Am. J. Clin. Nutr. 109(3), 626\u2013634 (2019).","journal-title":"Am. J. Clin. Nutr."},{"issue":"6","key":"85684_CR45","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.psyneuen.2008.12.010","volume":"34","author":"H Bruehl","year":"2009","unstructured":"Bruehl, H., Wolf, O. T. & Convit, A. A blunted cortisol awakening response and hippocampal atrophy in type 2 diabetes mellitus. Psychoneuroendocrinology 34(6), 815\u2013821 (2009).","journal-title":"Psychoneuroendocrinology"},{"issue":"9","key":"85684_CR46","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1055\/s-0031-1275288","volume":"119","author":"F Lederbogen","year":"2011","unstructured":"Lederbogen, F. et al. Flattened circadian cortisol rhythm in type 2 diabetes. Exp. Clin. Endocrinol. Diabetes 119(9), 573\u2013575 (2011).","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"2","key":"85684_CR47","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1210\/jc.2015-2853","volume":"101","author":"RA Hackett","year":"2016","unstructured":"Hackett, R. A. et al. Diurnal cortisol patterns, future diabetes, and impaired glucose metabolism in the whitehall II cohort study. J. Clin. Endocrinol. Metab. 101(2), 619\u2013625 (2016).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"85684_CR48","doi-asserted-by":"publisher","first-page":"525093","DOI":"10.1155\/2012\/525093","volume":"2012","author":"G Di Dalmazi","year":"2012","unstructured":"Di Dalmazi, G. et al. Glucocorticoids and type 2 diabetes: from physiology to pathology. J. Nutr. Metab. 2012, 525093 (2012).","journal-title":"J. Nutr. Metab."},{"issue":"3","key":"85684_CR49","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1210\/jc.2010-1942","volume":"96","author":"RN Clayton","year":"2011","unstructured":"Clayton, R. N. et al. Mortality and morbidity in Cushing\u2019s disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature. J. Clin. Endocrinol. Metab. 96(3), 632\u2013642 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl 1","key":"85684_CR50","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1055\/s-2007-1001104","volume":"25","author":"P Mair","year":"1990","unstructured":"Mair, P. et al. Infusion or repetitive bolus injection? A clinical study of midazolam\/fentanyl and diazepam\/fentanyl combination anesthesia in neurosurgical operations. Anasth. Intensivther. Notfallmed. 25(Suppl 1), 34\u201338 (1990).","journal-title":"Anasth. Intensivther. Notfallmed."},{"issue":"8","key":"85684_CR51","doi-asserted-by":"publisher","first-page":"e0134311","DOI":"10.1371\/journal.pone.0134311","volume":"10","author":"C Barrios","year":"2015","unstructured":"Barrios, C. et al. Gut-microbiota-metabolite axis in early renal function decline. PLoS ONE 10(8), e0134311 (2015).","journal-title":"PLoS ONE"},{"issue":"11","key":"85684_CR52","doi-asserted-by":"publisher","first-page":"e13953","DOI":"10.1371\/journal.pone.0013953","volume":"5","author":"K Suhre","year":"2010","unstructured":"Suhre, K. et al. Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting. PLoS ONE 5(11), e13953 (2010).","journal-title":"PLoS ONE"},{"issue":"5","key":"85684_CR53","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1373\/clinchem.2015.250761","volume":"62","author":"GFT Svingen","year":"2016","unstructured":"Svingen, G. F. T. et al. prospective associations of systemic and urinary choline metabolites with incident type 2 diabetes. Clin. Chem. 62(5), 755\u2013765 (2016).","journal-title":"Clin. Chem."},{"issue":"1","key":"85684_CR54","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1900\/RDS.2016.13.66","volume":"13","author":"Z Liu","year":"2016","unstructured":"Liu, Z. et al. Chronic exposure to proline causes aminoacidotoxicity and impaired beta-cell function: studies in vitro. Rev. Diabet. Stud. 13(1), 66\u201378 (2016).","journal-title":"Rev. Diabet. Stud."},{"issue":"12","key":"85684_CR55","doi-asserted-by":"publisher","first-page":"e1001765","DOI":"10.1371\/journal.pmed.1001765","volume":"11","author":"P Wurtz","year":"2014","unstructured":"Wurtz, P. et al. Metabolic signatures of adiposity in young adults: mendelian randomization analysis and effects of weight change. PLoS Med. 11(12), e1001765 (2014).","journal-title":"PLoS Med."},{"issue":"12","key":"85684_CR56","doi-asserted-by":"publisher","first-page":"2774","DOI":"10.1007\/s00125-015-3762-x","volume":"58","author":"C Andersson","year":"2015","unstructured":"Andersson, C. et al. Low-density-lipoprotein cholesterol concentrations and risk of incident diabetes: epidemiological and genetic insights from the framingham heart study. Diabetologia 58(12), 2774\u20132780 (2015).","journal-title":"Diabetologia"},{"issue":"7","key":"85684_CR57","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.2337\/db14-1710","volume":"64","author":"T Fall","year":"2015","unstructured":"Fall, T. et al. Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes. Diabetes 64(7), 2676\u20132684 (2015).","journal-title":"Diabetes"},{"issue":"6","key":"85684_CR58","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","volume":"1","author":"J White","year":"2016","unstructured":"White, J. et al. Association of lipid fractions with risks for coronary artery disease and diabetes. JAMA Cardiol 1(6), 692\u2013699 (2016).","journal-title":"JAMA Cardiol"},{"issue":"11","key":"85684_CR59","doi-asserted-by":"publisher","first-page":"2915","DOI":"10.2337\/db17-0199","volume":"66","author":"J Liu","year":"2017","unstructured":"Liu, J. et al. A Mendelian randomization study of metabolite profiles, fasting glucose, and type 2 diabetes. Diabetes 66(11), 2915\u20132926 (2017).","journal-title":"Diabetes"},{"issue":"11","key":"85684_CR60","doi-asserted-by":"publisher","first-page":"e1002179","DOI":"10.1371\/journal.pmed.1002179","volume":"13","author":"LA Lotta","year":"2016","unstructured":"Lotta, L. A. et al. Genetic predisposition to an impaired metabolism of the branched-chain amino acids and risk of type 2 diabetes: a mendelian randomisation analysis. PLoS Med. 13(11), e1002179 (2016).","journal-title":"PLoS Med."},{"issue":"5","key":"85684_CR61","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0197-0186(00)00112-1","volume":"38","author":"RA Kowluru","year":"2001","unstructured":"Kowluru, R. A. et al. Retinal glutamate in diabetes and effect of antioxidants. Neurochem. Int. 38(5), 385\u2013390 (2001).","journal-title":"Neurochem. Int."},{"issue":"9","key":"85684_CR62","first-page":"3109","volume":"43","author":"Q Li","year":"2002","unstructured":"Li, Q. & Puro, D. G. Diabetes-induced dysfunction of the glutamate transporter in retinal Muller cells. Investig. Ophthalmol. Vis. Sci. 43(9), 3109\u20133116 (2002).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"1","key":"85684_CR63","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1186\/s12933-019-0958-2","volume":"18","author":"C Razquin","year":"2019","unstructured":"Razquin, C. et al. Lysine pathway metabolites and the risk of type 2 diabetes and cardiovascular disease in the PREDIMED study: results from two case-cohort studies. Cardiovasc. Diabetol. 18(1), 151 (2019).","journal-title":"Cardiovasc. Diabetol."},{"issue":"9","key":"85684_CR64","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1016\/j.metabol.2016.06.007","volume":"65","author":"TC Carter","year":"2016","unstructured":"Carter, T. C. et al. Validation of a metabolite panel for early diagnosis of type 2 diabetes. Metabolism 65(9), 1399\u20131408 (2016).","journal-title":"Metabolism"},{"issue":"8","key":"85684_CR65","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/S0026-0495(03)00153-7","volume":"52","author":"H Sone","year":"2003","unstructured":"Sone, H. et al. Physiological changes in circulating mannose levels in normal, glucose-intolerant, and diabetic subjects. Metabolism 52(8), 1019\u20131027 (2003).","journal-title":"Metabolism"},{"key":"85684_CR66","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1172\/JCI104814","volume":"42","author":"FC Wood Jr","year":"1963","unstructured":"Wood, F. C. Jr. & Cahill, G. F. Jr. Mannose utilization in man. J. Clin. Investig. 42, 1300\u20131312 (1963).","journal-title":"J. Clin. Investig."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85684-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85684-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T20:10:50Z","timestamp":1675023050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-85684-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,18]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["85684"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-85684-7","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.10.30.20222836","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,18]]},"assertion":[{"value":"25 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6197"}}